Crossover in COAPT: Does This Extend the Reach of TMVr for Treating Functional MR?
J Am Coll Cardiol
.
2021 Mar 2;77(8):1041-1043.
doi: 10.1016/j.jacc.2021.01.001.
Authors
Jeremiah P Depta
1
,
Deepak L Bhatt
2
Affiliations
1
Sands Constellation Heart Institute, Rochester Regional Health, Rochester, New York, USA. Electronic address: Jeremiah.Depta@rochesterregional.org.
2
Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, Massachusetts, USA.
PMID:
33632477
DOI:
10.1016/j.jacc.2021.01.001
No abstract available
Keywords:
heart failure; mitral regurgitation; percutaneous; prognosis; randomized trial; treatment.
Publication types
Editorial
Comment
MeSH terms
Humans
Mitral Valve
Mitral Valve Insufficiency*